Get in touch

Greece’s Premier Pharmaceutical Cannabis Company

Greenleaf Medical is committed to growing high-quality pharmaceutical cannabis in Greece, to further provide local, European, and international markets with the final medical products derived from cannabis. We have broken ground on 38,000 sq. m plot in Kilkis, Northern Greece to create a high-tech cultivation and production facilities utilizing the latest advances in lighting, climate control, cultivation science and Integrated Pest Management for biologic pest control. Greenleaf will be delivering pharmaceutical cannabis products to companies, doctors, and patients; at a price affordable to all.



Greenleaf Medical has received a preliminary license for construction of the facility. We will be among the first companies in Greece to cultivate and produce medical cannabis.
Our license is published in the Government Paper on 20.6.2019, B 2430 under Ministerial Decree Number οικ.6490/804/Φ64.17


We have started the construction of a 14.000m² facility: 11.000m² for cultivation, and 3.000m² of production space.
Our extraction facilities will utilize the latest super critical CO2 extraction technology to allow for superior full-spectrum and isolate products.


Greenleaf Medical will be processing, extracting and creating final products under EU Good Manufacturing Practice standards that allows for patient focused tracking of production of the supply chain, as well as extensive biological, mycological, and pesticide testing.


Greenleaf Medical’s cultivation facilities are designed for a smooth workflow and a great working environment. This environment will also foster our guidelines when applying Good Manufacturing and Good Agricultural Practices.


Cultivating high-quality cannabis is best achieved through experienced and skilled staff.

To foster the industry and to provide for a stable workforce Greenleaf Medical will have an extensive training program to ensure our staff cultivates consistent and high-quality cannabis.


Through careful selection of strains and breeding programs, Greenleaf Medical will have novel strains and cannabinoid profiles to fit treatment for specific ailments.


The hybrid greenhouse design will allow Greenleaf Medical to use less energy in the cultivation of pharmaceutical cannabis.


Greenleaf Medical’s drying and processing systems ensure that the full spectrum of beneficial cannabinoids and terpenes are captured in the final product.

We create products you can rely on for consistency in both quality, pricing and supply.

Data collection

Total damage has been caused by the civilians arounf the new apple  store at Wall street.

Guaranteed ROI

Total damage has been caused by the civilians arounf the new apple  store at Wall street.

Always Online

Total damage has been caused by the civilians arounf the new apple  store at Wall street.


Each step in the process to the final product will be carefully monitored to ensure batch consistency, stability and compliance to all standards.

Cultivation Cycle

All post-extraction cannabis products will be composted and added back into the cultivation cycle.

Extraction Technology

Our extraction technology will allow for a wide variety of cannabis products as medical research points to ailments to be treated.


Treatments using Cannabis

With further research and discovering of the ideal combinations of cannabinoids and terpenes we hope to increase the effectiveness of cannabis and cannabis derived products for patients everywhere.

Meet the Team

CEO (Canada)

Director of Green Leaf Medical PC (Greece)

CFO (Greece)

Lead engineer (Greece)

Mechanical Engineer (Greece)

Master grower / Tech specialist (USA)

Master Grower

Lawyer / Head of legal department (Greece)

Extended team information

Greenleaf Labs

Investor Relations

Greenleaf Medical is open to partnerships in this or different affiliated facilities to meet the growing demand for pharmaceutical cannabis.

We focus on achieving top-quality cannabis production through an integrated approach incorporating worker training, patient feedback, biological science, and superior extraction technology.

Through strategic partnerships we can expand our model to provide a superior and consistent product throughout the continent and abroad, all while upholding the highest quality.

As cannabis markets around the world open there are opportunities to partner with us ensuring you a proven business model, supply-chain management and bureaucratic navigation. 

Contact our Investor Relations Department for more details.

Contact Investor Relations DepartmenT


We specialize in a wide array of medical fields and have some of the best facilities and doctors to take care of you.


We have an easy to understand at-a-glance proprietary labeling system highlighting the axis of cannabinoid and terpenes profile in each product, as well as a robust feedback system to provide data to doctors and researchers to further refine our understanding of both synergistic actions in the total profile of compounds, as well a potential understanding of genotype and phenotype variations that can adjust what each patient requires.


Cannabis strains come in a wide variety of relative amounts of active, helpful cannabinoids. Patient education is essential to empowering patients to communicate their needs to the medical professional. Greenleaf’s labeling system and educational graphics will allow the patient to effectively communicate back to their doctors what is working, how often treatment is needed and its effectiveness. Greenleaf’s aim is to help provide you with relief with minimal effort.

Doctors – Medical Professionals

A part of Greenleaf’s charter is to provide public education for doctors, medical professionals, pharmacists, and patients. This material will also provide easy to understand graphics to educate your patients as to what to expect with cannabis treatment.

We will be partnering organizations to provide data gathering for original studies from university and hospital trials from across the world. Especially promising uses will be the use of cannabis in opiate-dependency and withdrawal.

Other modules will include: seizure and epilepsy conditions, Cancer chemo symptoms as well as advances in cancer tumor treatments, anti-inflammation, and chronic pain relief treatments.

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from Youtube
Consent to display content from Vimeo
Google Maps
Consent to display content from Google
Consent to display content from Spotify
Sound Cloud
Consent to display content from Sound